Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA
12198
Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)
12198
Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)